The Evolving Role of High Efficacy, Anti-CD40 Therapeutics for Relapsing Multiple Sclerosis
Review of Biosimilar Therapeutics for Patients with Relapsing Multiple Sclerosis
Update on Clinical Data and Applications for Anti-CD20 Therapeutics to Treat Relapsing Multiple Sclerosis
